Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

By Wei-Ching Chang, Kerry L Lee, M. Akkerhuis, M. Simoons, Robert A. Harrington, Eric J. Topol, P. Armstrong, Robert M. Califf, M. Lincoff, K. Pieper and 4 more. Circulation, 2000

971 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/48efa3ff995e313b9366f387311d2baceb48d7ca

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Peter C. Austin
2. Hani Jneid
3. Allan S. Jaffe
4. Roger Mundry

Citations in the corpus

• A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. (2004, background): “Length of hospital stay, median (IQR), d Patients who died 8 (5-12) 6 (3-10) NA Patients discharged alive 6 (3-10) 6 (3-9) NA”
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Preferred options are eptifibatide or tirofiban (41,149,150).”